Sort by
Refine Your Search
-
Postdoctoral Fellow – Mitochondrial Microproteins & Therapeutic Innovation Lena Ho Lab | Duke-NUS Medical School, Singapore Cardiovascular & Metabolic Disorders Programme Advance scientific frontiers in one of Asia’s leading biomedical research hubs. Duke-NUS Medical School combines the academic...
-
(or conferences) in one or more of the following areas: Quantum machine learning, Quantum algorithms , Quantum information theory or Theoretical Physics Essential criteria: Proficiency in at least one programming
-
, and data outputs are robust, version-controlled, and reproducible, adhering to FAIR (Findable, Accessible, Interoperable, Reusable) principles. Disseminate research findings through journal publications
-
High Level (e.g. python) programming languages, Databases (SQL), development and maintaining code repositories (version control) Demonstrate Linux expertise including file systems, shell, hardware
-
coding in R, Matlab and/or Python, and already adapt to using the UNIX command line and executing analyses using high performance computing cluster. Preferred qualifications: Prior experience in analyzing
-
opportunities of exceptional postdoctoral researchers from around the world. Selected candidates will have the opportunity to develop their research ideas in one of four areas of quantum science: Quantum Theory
-
collaborator Ramiro Alberio at the University of Nottingham. The Living Systems Institute The Living Systems Institute (LSI) is a cross-Faculty research Institute that combines theory and technology from
-
-intensive field Proficiency in Python (or R), version control, and clean code practices Experience with omics data analysis and integration Hands-on expertise in developing and fitting executable models
-
similar mechanism controls the cell fate decision between mesoderm and definitive endoderm in humans, and if not, how this fate decision is controlled. To undertake this work, I am looking for a highly
-
-family kinases and their control of the RAS/RAF/Map kinase pathway (Park et al., Nature 2019; Park et al., Nature Communications 2023), mutational activation of EGFR in lung cancer (Jia et al., Nature 2016